Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.67 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.67 |
| ▸ | ACE | P12821 | 1/20 | 0.61 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | CTSS | P25774 | 6/20 | 0.55 |
| ▸ | CTSK | P43235 | 5/20 | 0.55 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 1/20 | 0.54 |
| ▸ | PPARA | Q07869 | 6/20 | 0.54 |
| ▸ | PPARG | P37231 | 5/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.53 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1311509 | 1.00 | ITGB3 (0.67) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL1062486 | 1.00 | ITGB3 (0.67) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL3824555 | 0.92 | ACE (0.62) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL16448042 | 0.91 | ITGB3 (0.64) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL12975375 | 0.91 | ITGB3 (0.64) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL27569374 | 0.90 | ITGB3 (0.56) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL27569376 | 0.90 | ITGB3 (0.56) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL11436862 | 0.89 | ABCB1 (0.56) | ITGB3ITGA2BACEABCB1PTPN1 | |
| SCHEMBL1308867 | 0.89 | ITGB3 (0.67) | ITGB3ITGA2BACEPTPN1CTSS | |
| SCHEMBL13252087 | 0.89 | ABCB1 (0.58) | ITGB3ITGA2BACEABCB1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| EP-4255885-A1 | IODOTYROSINE DERIVATIVES AND PROCESS FOR PREPARING IODOTYROSINE DERIVATIVES | ABX Advanced Biochemical Compounds GmbH (DE) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20230001024-A1 | CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF | NORTH CAROLINA STATE UNIVERSITY | 2023-01-05 | — | — | US | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| EP-4008713-A1 | IODINE TYROSINE DERIVATIVES AND METHOD FOR THE PREPARATION OF IODINE TYROSINE DERIVATIVES | ABX Advanced Biochemical Compounds GmbH (DE) | 2022-06-08 | — | — | EP | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| WO-2015090216-A1 | 6, 7-DIMETHOXY-1, 2, 3, 4-TETRAHYDROISOQUINOLINE DERIVATIVE AND MANUFACTURING METHOD THEREOF, PHARMACEUTICAL COMPOSITION COMPRISED THEREOF, AND APPLICATION THEREOF | 沈阳药科大学 | 2015-06-25 | — | — | WO | disclosed |
| US-20080318947-A1 | Inhibitors of Akt Activity | HEERDING DIRK A | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230001024-A1 | CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF | AOX1, MTCL3, COL1A1 | ITGB3 214/4885ITGA2B 145/4885ACE 2382/4885 |
| US-20080318947-A1 | Inhibitors of Akt Activity | PI4KB, PIK3CA, AKT2 | ITGB3 3387/4885ITGA2B 1964/4885ACE 4185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.